Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice
Judith Jacobi(Indiana University Health), Danielle Smidt(University of California Davis Medical Center), Ilya Danelich(AstraZeneca (South Korea)), Shaunta’ M. Ray(Knoxville College), Ed O’Donnell(Midwestern University), Stephen F Eckel(University of North Carolina Health Care), Roy Guharoy(Ascension), Stephanie M. Crist(University of Health Sciences and Pharmacy), Elizabeth Dodds Ashley(Duke University), Teena Sam(Baylor University Medical Center), Michael Militello(Cleveland Clinic)
Cited by 29
Related Papers
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
|Critical Care Medicine|2012|572
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
|JAMA Neurology|2024|88
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
|Journal of the American College of Surgeons|2014|73
Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2015|55
Role of clinical pharmacists and pharmacy support personnel in transitions of care
|JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY|2020|40